WeVote
Log In

Bill

Bill

SB 299

Stem cell therapy; permitted in certain circumstances, notice and consent requirements provided, exceptions provided, State Board of Medical Examiners required to adopt rules

2025 Regular Session Introduced by Tim Melson

Alabama bill permits stem cell therapies with state medical board oversight, patient consent requirements, and regulatory exceptions to protect and enable treatment access.

Read for the first time and referred to the Senate Committee on Healthcare
#health
0
WeVote Research Nonpartisan
Bill Summary · SB 299

Legislative bill overview

SB 299 would permit stem cell therapies in Alabama under specific circumstances while establishing notice and consent requirements for patients. The bill directs the State Board of Medical Examiners to develop regulatory rules governing these treatments, with certain exceptions built into the framework.

Why is this important

Stem cell therapy remains a rapidly evolving medical field with significant therapeutic potential but also unproven treatments being marketed to desperate patients. This legislation attempts to balance innovation access with patient protection through regulatory oversight and informed consent safeguards in Alabama's medical practice.

Potential points of contention

  • Scope ambiguity: The bill's language regarding "certain circumstances" and what exceptions apply could create uncertainty about which stem cell therapies qualify, potentially leading to regulatory inconsistency
  • Patient protection vs. innovation: Balancing permitting access to emerging treatments against protecting vulnerable patients from unproven or fraudulent stem cell clinics that operate with minimal oversight
  • Regulatory development: The Board's rule-making authority and timeline are unclear, potentially leaving a gap between legalization and actual regulatory guidance for practitioners

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.